The new study, a collaboration of 130 hospitals in 31 countries, has shown that opening all the blockages is better than treating only the one blockage causing the heart attack. This led to a 26 per cent reduction in the patient’s risk of dying or having a recurrent heart attack.
In a study published online in the International Journal of Cardiology, researchers at Beth Israel Deaconess Medical Center (BIDMC) examined the effects of three healthy diets emphasizing different macronutrients – carbohydrates, proteins, or unsaturated fats – on a biomarker that directly reflects heart injury. The team found that all three diets reduced heart cell damage and inflammation, consistent with improved heart health.
An international team of researchers received a five-year, $3.1 million grant from the National Institutes of Health to discover new and better ways to treat a pediatric congenital heart condition known as tetralogy of Fallot
Xinzhu (Shin) Pu, an assistant research professor in Boise State University’s biology department and Biomolecular Research Center, has been awarded a one-year renewable grant of $50,000 by the IDeA Network of Biomedical Research Excellence (Idaho INBRE) to fund a pilot study related to the heart-damaging effects of Doxorubicin.
A literature review by a team at the VA Portland Health Care System and Oregon Health & Science University found evidence that biofeedback can be a helpful treatment for several conditions.
A review of more than 100 studies suggests that balancing hormone levels may reverse factors that increase heart disease risk in some female athletes. The review is published ahead of print in the American Journal of Physiology—Heart and Circulatory Physiology.
Der Besitz eines Haustieres kann nach der ersten Analyse von Daten aus der Studie „Kardiozive Brno 2030“ zur Erhaltung eines gesunden Herzens beitragen, insbesondere wenn es sich bei diesem Haustier um einen Hund handelt. Die Studie untersucht den Zusammenhang von der Haustierhaltung - insbesondere der Hundehaltung - mit Risikofaktoren für kardiovaskuläre Erkrankungen und die kardiovaskuläre Gesundheit.
对Kardiozive Brno 2030研究数据的初步分析发现，养宠物有利于保持心脏健康，尤其是养狗。该研究旨在验证养宠物（尤其是养狗）与心血管疾病风险因素及心血管健康之间的联系。该研究成果已在Mayo Clinic Proceedings: Innovations, Quality & Outcome上发表。
Posséder un animal de compagnie pourrait aider à préserver la bonne santé cardiovasculaire, notamment s’il s'agit d'un chien, selon l’analyse initiale des données issues de l’étude Kardiozive Brno 2030. L'étude examine le lien entre le fait de posséder un animal de compagnie, notamment un chien, et les facteurs de risque de maladie cardiovasculaire et la santé cardiovasculaire.
Ter um animal de estimação pode ajudar a manter o coração saudável, principalmente se esse animal de estimação for um cachorro, de acordo com a primeira análise dos dados do estudo Kardiozive Brno 2030.
Tener una mascota puede ayudar a conservar la salud cardíaca, especialmente cuando esa mascota es un perro, dice el primer análisis de datos del estudio Kardiozive Brno 2030. El estudio examina la relación entre tener una mascota —específicamente, un perro— y los factores de riesgo para enfermedades cardiovasculares y la salud cardiovascular misma.
Owning a pet may help maintain a healthy heart, especially if that pet is a dog, according to the first analysis of data from the Kardiozive Brno 2030 study. The study examines the association of pet ownership — specifically dog ownership — with cardiovascular disease risk factors and cardiovascular health. The results are published in Mayo Clinic Proceedings: Innovations, Quality & Outcomes.
The amount of opioids prescribed for patients after heart and lung surgery has a direct relationship with the risk for opioid dependency and “persistent opioid use” several months after the operation.
On Aug. 16, the U.S. Food and Drug Administration (FDA) approved a minimally invasive open-heart surgery alternative for low surgical-risk patients following the successful outcome of the PARTNER 3 and Evolut LR clinical trials. Baylor Scott & White The Heart Hospital – Plano and Baylor Scott & White Medical Center – Temple participated in the PARTNER 3 trial and Baylor Scott & White Heart and Vascular Hospital – Dallas participated in the Evolut LR trial, following FDA approval of transcatheter aortic valve replacement (TAVR) for inoperable patients in 2012, high-risk patients in 2014 and medium-risk patients in 2017.
Scientists at Johns Hopkins have successfully created personalized digital replicas of the upper chambers of the heart and used them to guide the precise treatment of patients suffering from persistent irregular heartbeats. These simulations accurately identified where clinicians need to destroy tissue to restore the heart’s normal rhythm.
Scientists at the Fralin Biomedical Research Institute at VTC -- a research institute of Virginia Tech -- discovered a new compound that could shield heart tissue before a heart attack, as well as preserve healthy cells when administered afterward.
New research suggests LVADs may not solve mitral regurgitation for some patients with poor right heart function.
The study found that ‘silent’ covert strokes are actually more common than overt strokes in people aged 65 or older who have surgery
MyoKardia, Inc. today announced the launch of the 2nd Annual MyoSeeds™ Research Grants Program, an initiative to support original, independent research in the biology and underlying mechanisms of cardiomyopathies and precision heart disease treatment.
Castleman Disease patients who do not respond to the only drug currently approved by the FDA may have another option that targets a specific pathway called PI3K/Akt/mTOR
Hui Yang, Harold and Inge Marcus Career Associate Professor of Industrial and Manufacturing Engineering at Penn State, was awarded a $320,625 grant from the National Science Foundation (NSF) to study exactly how a process called glycosylation can cause proteins to disrupt the harmony of cell activity.
The human heart’s energy needs and functions are difficult to reproduce in other animals; one new system looks to circumvent these issues and provide a functional view of how different treatments can help ailing cells in the heart following oxygen and nutrient deprivations. Researchers have unveiled a new silicon chip that holds human lab-grown heart muscle cells for assessing the effectiveness of new drugs. They discuss their work in this week’s APL Bioengineering.
Consuming flavonoid-rich items such as apples and tea protects against cancer and heart disease, particularly for smokers and heavy drinkers, according to new research from Edith Cowan University (ECU).
Common prostate cancer therapy may increase short-term risk of death in patients with pre-existing cardiovascular conditions.
A new grant will study why the newborn mammalian heart can repair itself, an ability that vanishes a few days after birth. Aims are to decipher mechanisms that govern that neonatal regenerative potential, and see if those mechanisms can be manipulated to remuscularize hearts after heart attack.
Most people with a medical condition called long QT syndrome have a mutation in a gene that causes bouts of fast, chaotic heartbeats. They also experience fainting spells and seizures. The clinical approach has largely assumed that when the heart beats erratically, the brain eventually does not get enough oxygen — which in turn causes the seizures.
The Cardiovascular Research Foundation (CRF) has announced the 12 late-breaking trials and 16 late-breaking science presentations that will be reported at the Transcatheter Cardiovascular Therapeutics (TCT) 2019 scientific symposium. TCT, the world’s premier educational meeting specializing in interventional cardiovascular medicine, will take place September 25 – 29, 2019 at The Moscone Center in San Francisco, California.
The numerous insights and resources gained by health care providers, stroke survivors, and their caregivers during the COMPASS post-acute stroke services study are available to anyone online through the COMPASS study website.
In a Phase III clinical trial, the drug volanesorsen significantly reduced blood fat (triglyceride) levels in participants with a rare disease called familial chylomicronemia syndrome; finding could also help inform better prevention methods and treatments for many types of heart disease.
The heart cannot regenerate muscle after a heart attack. Injecting heart muscle cells grown in vitro could help the failing heart, but engraftment rates are low. A new and simple method to improve the quality of the delivered cells has now been tested in mice, and it doubles the engraftment rate.
One of the most common problems cardiologists handle is atrial fibrillation, an abnormal or irregular heartbeat that can lead to blood clots, stroke, heart failure and other heart-related complications.
The heart transplant program at UC San Diego Health has demonstrated the best one-year survival rate for patients in the United States among health care providers with a volume of more than 50 heart transplants per year, according to the Scientific Registry of Transplant Recipients.
On August 4, a special session at the 71st AACC Annual Scientific Meeting & Clinical Lab Expo will shed much-needed light on the nuances of direct-to-consumer genetic testing.
Una nueva investigación de Mayo Clinic muestra que la inteligencia artificial puede detectar en un electrocardiograma (ECG) las señales de la arritmia cardíaca llamada fibrilación auricular, aunque el ritmo cardíaco sea normal en el momento del examen. Es decir, el ECG mediante inteligencia artificial puede detectar una fibrilación auricular que ocurrió recién y sin síntomas o que es inminente, lo cual mejoraría las alternativas terapéuticas. Con este estudio, puede aumentar la eficacia del ECG.
A new Mayo Clinic research study shows that artificial intelligence (AI) can detect the signs of an irregular heart rhythm — atrial fibrillation (AF) — in an EKG, even if the heart is in normal rhythm at the time of a test. In other words, the AI-enabled EKG can detect recent atrial fibrillation that occurred without symptoms or that is impending, potentially improving treatment options. This research could improve the efficiency of the EKG, a noninvasive and widely available method of heart disease screening. The findings and an accompanying commentary are published in The Lancet.
一项I期临床试验表明，通过采集和处理婴儿自体干细胞并在手术时直接将其注入心脏，有望对左心发育不良综合征(HLHS)进行再生治疗。该研究是美国食品药品监督管理局监测的首项同类研究。The Journal of Thoracic and Cardiovascular Surgery（《胸心血管外科杂志》）上发表了一篇详细介绍该临床试验的论文。
A study from the University of Pittsburgh Graduate School of Public Health shows that using an estradiol patch was associated with accumulation of fat around the heart and worsening of coronary artery calcification.
A newly developed technique that shows artery clogging fat-and-protein complexes in live fish gave investigators from Carnegie
Researchers at Iowa State University have developed a model to test how shading and air flow can improve indoor temperatures during the sweltering heat of Midwest summers.
Measuring waistline, blood pressure, cholesterol, blood fats, and blood sugar during doctor visits can detect heart disease and diabetes earlier, according to a Clinical Practice Guideline issued today by the Endocrine Society.
A wireless, wearable monitor built with stretchable electronics could allow comfortable, long-term health monitoring of adults, babies and small children without concern for skin injury or allergic reactions caused by conventional adhesive sensors with conductive gels.
For a third consecutive year, UT Southwestern Medical Center is the No. 1 hospital in Dallas-Fort Worth and No. 2 in Texas, according to U.S. News & World Report’s annual Best Hospitals listings released today. UT Southwestern also ranked nationally in seven specialties including heart and neurological care.
The chances of patients experiencing complications after having a cardiac device implanted vary according to where they have the procedure.
The pivotal trial to determine the safety and effectiveness of a modular device designed to be the first completely off-the-shelf endovascular solution for aortic aneurysms involving the visceral branch vessels is successfully underway with its first surgery at UNC Hospitals in Chapel Hill, NC.
Researchers at Beth Israel Deaconess Medical Center (BIDMC) have developed a novel imaging approach that has the potential to identify patients with coronary disease without administration of drugs or contrast dye and within a short 15 minute exam protocol.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right